The Effect of Su Jok Therapy on Postoperative Pain, Anxiety and Patient Satisfaction in Patients With BPH
NCT ID: NCT06456632
Last Updated: 2024-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
52 participants
INTERVENTIONAL
2024-07-01
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of the Music With Structured Verbal Training During Prostate Biopsy
NCT04466202
Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy
NCT02620033
The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly
NCT01342562
Pain and Anxiety During Transrectal Prostate Biopsy
NCT05358223
Risk Factors and Impact of Anesthesia Techniques on Myocardial Infarction Following Transurethral Resection of the Prostate
NCT04047329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Hypotheses:
H0-1: Su Jok therapy is not effective in reducing postoperative pain level in patients undergoing TUR-P.
H1-1: Su Jok therapy is effective in reducing postoperative pain level in patients undergoing TUR-P.
H0-2: Su Jok therapy is not effective in reducing anxiety level in patients undergoing TUR-P.
H1-2: Su Jok therapy is effective in reducing anxiety level in patients undergoing TUR-P.
H0-3: Su Jok therapy is not effective in increasing patient satisfaction in patients undergoing TUR-P.
H1-3: Su Jok therapy is effective in increasing patient satisfaction in patients undergoing TUR-P.
The population of this study will consist of patients who applied to the Urology Outpatient Clinic of Başkent University Ankara Hospital and were planned to undergo Transurethral Prostate Resection for the first time with the diagnosis of BPH.
According to hospital records, 52 patients diagnosed with BPH underwent TUR-P in the last year. The sample size of the study was calculated by a statistical expert using a sample size calculation program (G\*Power version 3.1.9.4). The minimum sample size required for the study was planned to include at least 52 patients (26 intervention, 26 control) to be approximately equally distributed in the groups that will provide 80% test power at 95% confidence level, with an effect size of 0.80 and Cohen's large effect size of 0.80 for "One-Way Analysis of Variance" when the parametric test assumptions of "Whether there is a difference between more than two groups" are met, and "Kruskal Wallis Test" when not met.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Group not receiving Su Jok Therapy
No interventions assigned to this group
Intervention Group
Group receiving Su jok therapy
Intervention Su Jok Therapy
Su Jok Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention Su Jok Therapy
Su Jok Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First time undergoing TUR-P surgery,
* Does not have any cognitive, affective and verbal communication problems that prevent understanding of the information given and expressing the pain and anxiety correctly,
* Patients who volunteered to participate in the study
Exclusion Criteria
* HbA1c value in patients diagnosed with diabetes mellitus: 6.5% and above
* Using any complementary and integrative health practice in the last 3 months,
* Patients who do not speak Turkish, have hearing problems, language problems
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA24/89
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
KA24/89
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.